280 related articles for article (PubMed ID: 24018025)
1. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.
Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335
[TBL] [Abstract][Full Text] [Related]
3. Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?
Alsan Cetin I; Akgun Z; Atasoy BM; Fulden Yumuk P; Abacioglu U
J BUON; 2013; 18(2):453-8. PubMed ID: 23818361
[TBL] [Abstract][Full Text] [Related]
4. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
Ceresoli GL; Reni M; Chiesa G; Carretta A; Schipani S; Passoni P; Bolognesi A; Zannini P; Villa E
Cancer; 2002 Aug; 95(3):605-12. PubMed ID: 12209754
[TBL] [Abstract][Full Text] [Related]
7. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
11. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
13. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
14. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
15. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
[TBL] [Abstract][Full Text] [Related]
16. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
17. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.
Namba Y; Kijima T; Yokota S; Niinaka M; Kawamura S; Iwasaki T; Takeda Y; Kimura H; Okada T; Yamaguchi T; Nakagawa M; Okumura Y; Maeda H; Ito M
Clin Lung Cancer; 2004 Sep; 6(2):123-8. PubMed ID: 15476598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]